Author
Listed:
- Oguntayo Rotimi
(Department of Psychology, Faculty of Social Sciences, University of Ilorin, Ilorin, Nigeria)
- Olaseni Abayomi O.
(Department of Psychology, Faculty of Social Sciences, University of Ilorin, Ilorin, Nigeria)
- Ogundipe Abiodun Emmanuel
(Miami University Institute for the Environment and Sustainability (IES) Affiliate, Geography Department, College of Arts and Sciences, USA)
Abstract
This study examined the prevalence, socioeconomic and cognitive barriers of coronavirus vaccinations in Nigeria. The study used an ex-post facto design. 526-participants were sampled using snowball sampling technique. A questionnaire pack containing socio-demographics and a 13-item adapted scale of SYKES was used. Findings revealed the prevalence of COVID-19 vaccination hesitancy (61.7%). Adolescents (83.8%) recorded more hesitancy than participants in early-adulthood (62.7%), middle-adulthood (53.1%), and late-adulthood (53%). Males (83.8%) showed hesitancy than the females (33.3%). More so, the primary (62.5%) and secondary school certificate holders (41.4%) scored more on hesitancy than tertiary certificate holders (36.0%). The identified perceived barriers to vaccinations are: safety (91%); government distrust (75.5%) and coerciveness (65.7%), vaccines efficacy (62.5%), complacency (65.7%), and constraints to vaccination center (55.5%). Conclusively, vaccination hesitancy was found more among males and younger respondents. Safety and efficacy of the vaccines, government distrust, coercive approach, and complacency were found as major barriers.
Suggested Citation
Oguntayo Rotimi & Olaseni Abayomi O. & Ogundipe Abiodun Emmanuel, 2021.
"Hesitancy Prevalence and Sociocognitive Barriers to Coronavirus Vaccinations in Nigeria,"
European Review of Applied Sociology, Sciendo, vol. 14(23), pages 24-33, December.
Handle:
RePEc:vrs:erapso:v:14:y:2021:i:23:p:24-33:n:2
DOI: 10.2478/eras-2021-0008
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:vrs:erapso:v:14:y:2021:i:23:p:24-33:n:2. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Peter Golla (email available below). General contact details of provider: https://www.sciendo.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.